Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:11 pm Sale | 2026-06-30 | 13G | RELAY THERAPEUTICS INC RLAY | Commodore Capital LP | 12,000,000 5.500% | -5,000,000 (-29.41%) | Filing History |
| 2026-08-10 4:00 pm Purchase | 2026-06-30 | 13G | RELAY THERAPEUTICS INC RLAY | Perceptive Advisors LLC | 14,106,187 6.400% | 13,667,716 (+3117.13%) | Filing History |
| 2026-08-07 11:19 am Purchase | 2026-07-31 | 13G | RELAY THERAPEUTICS INC RLAY | FMR LLC | 21,270,751 10.000% | 1,255,638 (+6.27%) | Filing History |
| 2026-08-06 10:38 am Purchase | 2026-06-30 | 13G | RELAY THERAPEUTICS INC RLAY | FMR LLC | 20,015,113 9.400% | 17,058,892 (+577.05%) | Filing History |
| 2026-05-15 4:23 pm Sale | 2026-03-31 | 13G | RELAY THERAPEUTICS INC RLAY | Point72 Asset Management, L.P. | 0 0.000% | -13,445,704 (Position Closed) | Filing History |
| 2026-04-13 4:00 pm Sale | 2026-04-06 | 13G | KIORA PHARMACEUTICALS INC KPRX | Perceptive Advisors LLC | 438,471 9.990% | -8,966,254 (-95.34%) | Filing History |
| 2026-03-27 11:34 am Sale | 2026-03-13 | 13G | RELAY THERAPEUTICS INC RLAY | The Vanguard Group | 0 0.000% | -9,379,851 (Position Closed) | Filing History |
| 2026-03-19 4:07 pm Purchase | 2026-03-12 | 13G | RELAY THERAPEUTICS INC RLAY | Perceptive Advisors LLC | 9,404,725 5.300% | 9,404,725 (New Position) | Filing History |
| 2026-02-17 4:47 pm Unchanged | 2025-12-31 | 13G | RELAY THERAPEUTICS INC RLAY | Casdin Capital LLC | 13,003,574 7.500% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:45 pm Purchase | 2025-12-31 | 13G | RELAY THERAPEUTICS INC RLAY | Casdin Capital LLC | 13,003,574 7.500% | 5,615,631 (+76.01%) | Filing History |
| 2025-11-14 4:30 pm Purchase | 2025-09-30 | 13G | RELAY THERAPEUTICS INC RLAY | Commodore Capital LP | 17,000,000 9.900% | 3,650,000 (+27.34%) | Filing History |
| 2025-08-14 5:07 pm Purchase | 2025-06-30 | 13G | RELAY THERAPEUTICS INC RLAY | Commodore Capital LP | 13,350,000 7.800% | 3,350,000 (+33.50%) | Filing History |
| 2025-08-14 4:56 pm Purchase | 2025-06-30 | 13G | RELAY THERAPEUTICS INC RLAY | Point72 Asset Management, L.P. | 13,445,704 7.800% | 3,751,487 (+38.70%) | Filing History |
| 2025-07-29 2:22 pm Sale | 2025-06-30 | 13G | RELAY THERAPEUTICS INC RLAY | The Vanguard Group | 9,379,851 5.470% | -2,725,569 (-22.52%) | Filing History |
| 2025-05-15 4:05 pm Purchase | 2025-05-08 | 13G | RELAY THERAPEUTICS INC RLAY | Commodore Capital LP | 10,000,000 5.800% | 10,000,000 (New Position) | Filing History |
| 2025-04-30 11:12 am Purchase | 2025-03-31 | 13G | RELAY THERAPEUTICS INC RLAY | The Vanguard Group | 12,105,420 7.140% | 1,455,033 (+13.66%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | RELAY THERAPEUTICS INC RLAY | BlackRock, Inc. BLK | 10,308,012 6.100% | -4,366,250 (-29.75%) | Filing History |
| 2025-03-20 6:13 pm Purchase | 2025-03-14 | 13G | RELAY THERAPEUTICS INC RLAY | Point72 Asset Management, L.P. | 9,694,217 5.700% | 9,694,217 (New Position) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | RELAY THERAPEUTICS INC RLAY | BlackRock, Inc. BLK | 14,674,262 8.800% | 5,100,839 (+53.28%) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | RELAY THERAPEUTICS INC RLAY | T. Rowe Price Associates, Inc. | 5,280,291 3.300% | -3,309,134 (-38.53%) | Filing History |